JAMDA
April 21, 2023
Showing 11 - 20 of 53 results
JAMDA
August 31, 2022
Relationship between Diabetes Status and Sarcopenia in Community-Dwelling Older Adults
Diabetes mellitus (DM) is associated with risk of sarcopenia. However, whether glycated hemoglobin (HbA1c) levels are associated with sarcopenia has not reached a consensus. The purpose of this study was to examine the association between diabetes status based on HbA1c levels and sarcopenia indices in comm...
JAMDA
May 31, 2022
The Impact of Dementia on Diabetes Control: An Evaluation of HbA Trajectories and Care Outcomes in Linked Primary and Specialist Care Data1cThe Impact of Dementia on Diabetes Control: An Evaluation of HbA Trajectories and Care Outcomes in Linked Primary a
Diabetes self-care may become increasingly challenging as cognition declines. We sought to characterize glycated hemoglobin A (HbA) trajectories, markers of diabetes-related management, health care utilization, and mortality in people with preexisting type 2 diabetes (T2D) with and without dementia and bas...
JAMDA
February 17, 2022
Effect of Aerobic and Resistant Exercise Intervention on Inflammaging of Type 2 Diabetes Mellitus in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis
To examine the effect of aerobic and resistant exercise intervention on inflammaging in middle-aged and older adults with type 2 diabetes mellitus (T2DM) using inflammatory cytokines, such as interleukin (IL)-1 β, IL-6, tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) as biomarkers.
Podcast
September 27, 2021
JAMDA On-The-Go | September 2021 | Individualizing Diabetes Care in Persons with Multimorbidity
JAMDA
July 12, 2021
Two-Year Follow-up of a Multimodal Intervention on Functional Capacity and Muscle Power in Frail Patients With Type 2 Diabetes
To analyze the effects of a program composed of resistance training and nutritional interventions on functional capacity, maximal strength, and power output after 2 years of follow-up, including 2 periods of 16 weeks of intervention followed by several weeks of intervention cessation in frail patients with...
JAMDA
June 1, 2021
Hypoglycemia in Older Adults: Time Trends and Treatment Differences in Patients Aged ≥75 Years With Type 2 Diabetes
Hypoglycemia is a potentially life-threatening drug event under antidiabetic treatment. The aim of the study was to examine time trends in severe hypoglycemia in older adults with type 2 diabetes mellitus (T2DM) and antidiabetic treatment.
JAMDA
May 15, 2021
Potential Overtreatment and Undertreatment of Type 2 Diabetes Mellitus in Long-Term Care Facilities: A Systematic Review
To investigate the prevalence, outcomes, and factors associated with potential glycemic overtreatment and undertreatment of type 2 diabetes mellitus (T2DM) in long-term care facilities (LTCFs).
JAMDA
March 31, 2021
Diabetes and Prediabetes Inhibit Reversion from Mild Cognitive Impairment to Normal Cognition
Diabetes and prediabetes contribute to an increased risk of cognitive decline and dementia. Currently, it remains unclear whether elevated blood HbA1c levels, including prediabetes levels, affect reversion from mild cognitive impairment (MCI) to normal cognition. This study, therefore, aimed to examine the...
JAMDA
December 2, 2020
Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study
Type 2 diabetes is a risk factor for sarcopenia. Evidence on the prevention of sarcopenia using blood glucose–lowering therapy is limited. We aimed to examine the relationship between changes in glycemic control and sarcopenia and the effect of antidiabetic agents against sarcopenia in patients with type 2...
